In the context of chemotherapy, a study provided evidence that the NLRP3 inflammasome including caspase-1 are important for the induction of tumor-specific IFNγ producing helper CD4+ T cells, since Th1 priming failed in NLRP3 or caspase-1 deficient mice [194]. This evidence concerns the gene CD4 and neoplasm.